Clinical Trials Browser

Phase 3 × Interventional × Sunitinib × Clear all

Carcinoma, Renal Cell

Gastrointestinal Stromal Tumors

Carcinoma, Renal Cell

Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

Carcinoma, Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms by Site, Urologic Neoplasms

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

Carcinoma, Renal Cell, Kidney Neoplasms

Gastrointestinal Stromal Tumors

Primary Disease: Unresectable or Metastatic Renal Cell Carcinoma Focus of the Study:PFS Assessed by IRC Per RECIST 1.1

Carcinoma, Renal Cell

Carcinoma, Renal Cell

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Renal Cell

Carcinoma, Renal Cell

Carcinoma, Renal Cell

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

Carcinoma, Renal Cell

Advanced Renal Cancer

Gastrointestinal Stromal Tumors

Carcinoma, Renal Cell, Kidney Neoplasms

Carcinoma, Renal Cell

Neoplasm Metastasis, Gastrointestinal Stromal Tumors

Kidney Neoplasms

Carcinoma, Renal Cell

Carcinoma, Renal Cell, Neoplasms, Patient Preference

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular

Breast Neoplasms

Breast Neoplasms

Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumors

Pancreatic Neoplasms, Carcinoma, Islet Cell

Carcinoma, Renal Cell

Gastrointestinal Stromal Tumors

Clinical Trials

CLEAR

INTRIGUE

KEYNOTE-426

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

IMbrella B

Savolitinib vs. Sunitinib in MET-driven PRCC.

ACTION-1

STROKER

INSIGHT

Study to Evaluate the Efficacy and Safety of Toripalimab in Combination With Axitinib Versus Sunitinib Monotherapy in Advanced Renal Cell Cancer

A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI

CARMENA

JAVELIN Renal 101

Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302)

Nivolumab Combined With Ipilimumab Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 214)

CheckMate 9ER

SAMETA

COMPARZ

A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Sunitinib in Subjects With Advanced Renal Cancer

Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Patients After Failure of Imatinib

A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)

IMmotion151

Masitinib in Patients With Gastrointestinal Stromal Tumour After Progression With Imatinib

S-TRAC

IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma

PISCES

Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer

A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer

SUN 1064

A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer

ENEST

Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors

A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors

SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma

A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST)